Anticancer biangeloyl saponins
US7514412B2 · kind B2 · utility
11Cited by
3References
23Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 27, 2005 |
| Grant date | Apr 7, 2009 |
| Priority date | — |
| Expiry date | Feb 11, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07J63/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Novel compounds such as compounds designated herein as Y or Y3, Y1, Y2, Y8, Y9 and Y10 are disclosed. These compounds have anticancer activity. The compounds of the present invention are obtainable from plants in the sapindaceae family, such as Xanthoceras sorbifolia, or other natural sources or products. The compounds of the present invention may also be synthesized chemically.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.